Diazepam
Product Images NDC 61919-367

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diazepam (NDC 61919-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label)

FDA Label Image

Image Description (Molecule)

FDA Label Image

Image Description (Table)

Image Description (Table)
This text provides information on the usual daily dose of a medication used for the management of anxiety disorders, relieving symptoms of anxiety, symptomatic relief in acute alcohol withdrawal, the relief of skeletal muscle spasm, and in convulsive disorders. Geriatric patients and those with debilitating daily disease have their own specified dosages. The medication is not to be used on children under 6 months, and for pediatric patients, therapy should be initiated at the lowest dose and then gradually increased as needed and tolerated.*
FDA Label Image

Image Description (Diazepam530)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.